Panbela Therapeutics Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Panbela Therapeutics.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs earnings growth | 35.6% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2024 | N/A | -38 | -19 | -20 | N/A |
| 3/31/2024 | N/A | -36 | -24 | -25 | N/A |
| 12/31/2023 | N/A | -34 | -25 | -25 | N/A |
| 9/30/2023 | N/A | -24 | -27 | -27 | N/A |
| 6/30/2023 | N/A | -20 | -22 | -22 | N/A |
| 3/31/2023 | N/A | -36 | -21 | -21 | N/A |
| 12/31/2022 | N/A | -35 | -16 | -15 | N/A |
| 9/30/2022 | N/A | -34 | -13 | -13 | N/A |
| 6/30/2022 | N/A | -31 | -13 | -12 | N/A |
| 3/31/2022 | N/A | -12 | -10 | -10 | N/A |
| 12/31/2021 | N/A | -10 | -7 | -7 | N/A |
| 9/30/2021 | N/A | -7 | -6 | -6 | N/A |
| 6/30/2021 | N/A | -7 | -6 | -6 | N/A |
| 3/31/2021 | N/A | -5 | -5 | -5 | N/A |
| 12/31/2020 | N/A | -5 | -4 | -4 | N/A |
| 9/30/2020 | N/A | -5 | -4 | -4 | N/A |
| 6/30/2020 | N/A | -5 | -3 | -3 | N/A |
| 3/31/2020 | N/A | -6 | -3 | -3 | N/A |
| 12/31/2019 | N/A | -6 | -3 | -3 | N/A |
| 9/30/2019 | N/A | -6 | -2 | -2 | N/A |
| 6/30/2019 | N/A | -6 | -2 | -2 | N/A |
| 3/31/2019 | N/A | -6 | -3 | -3 | N/A |
| 12/31/2018 | N/A | -6 | -2 | -2 | N/A |
| 9/30/2018 | N/A | -7 | -3 | -3 | N/A |
| 6/30/2018 | N/A | -8 | -3 | -3 | N/A |
| 3/31/2018 | N/A | -7 | N/A | -3 | N/A |
| 12/31/2017 | N/A | -10 | N/A | -3 | N/A |
| 9/30/2017 | N/A | -10 | N/A | -3 | N/A |
| 6/30/2017 | N/A | -10 | N/A | -4 | N/A |
| 3/31/2017 | N/A | -10 | N/A | -3 | N/A |
| 12/31/2016 | N/A | -5 | N/A | -2 | N/A |
| 9/30/2016 | N/A | -4 | N/A | -2 | N/A |
| 6/30/2016 | N/A | -3 | N/A | -2 | N/A |
| 3/31/2016 | N/A | -4 | N/A | -4 | N/A |
| 12/31/2015 | N/A | -5 | N/A | -4 | N/A |
| 9/30/2015 | N/A | -5 | N/A | -4 | N/A |
| 6/30/2015 | N/A | -6 | N/A | -4 | N/A |
| 3/31/2015 | N/A | -5 | N/A | -4 | N/A |
| 12/31/2014 | N/A | -4 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if X70's forecast earnings growth is above the savings rate (0.8%).
Earnings vs Market: Insufficient data to determine if X70's earnings are forecast to grow faster than the German market
High Growth Earnings: Insufficient data to determine if X70's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if X70's revenue is forecast to grow faster than the German market.
High Growth Revenue: Insufficient data to determine if X70's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if X70's Return on Equity is forecast to be high in 3 years time